Leader Biomedical’s OssGro® line is produced with MBCP™ Technology, a method producing biphasic bone substitutes closely resembling natural bone, both in structure and composition, for optimal new bone formation.
Chemical synthesis of calcium and phosphate salts under controlled temperature and pressure
Controlled synthesis forms precise ratios of hydroxyapatite (60%) and beta calcium phosphate (40%) ensuring quality and homogeneity
Sublimation under controlled temperature and pressure creates an even distribution of macropores in the graft when porogen converts into a gas and evaporates
Graft with evenly distributed macropores ensures effective cell colonisation and vascularisation
Sintering is performed at an ultra low temperature ensuring the graft forms and maintains micropores, while preventing fusion of pores
Graft with evenly distributed micropores ensures effective permeability and healthy bone regeneration